Related Experiment Video
Updated: Aug 5, 2025

BioMEMS: Forging New Collaborations Between Biologists and Engineers
Published on: November 1, 2007
Defense Advanced Research Projects Agency: Comment on 'Engineering biology and the grand challenges: Do we need a new
Ilya Klabukov1, Olga Krasilnikova1
1Department of Regenerative Technologies and Biofabrication National Medical Research Radiological Center 4 Koroleva St. Obninsk Russia.
Abstract:
This comment paper refers to the article published by Gauvreau et al. in Engineering Biology in 2018. Gauvreau et al. discussed various civilian models in the private and public sectors that could boost R&D plus Innovation (R&D&I) progress in the environmental sphere. The authors concluded that there is no tried-and-tested R&D&I model for engineering biology that is suited to help solve the problems of many grand and interacting challenges, and further, that the required model will not work without the private sector, so governments must collaborate to develop such a model. However, the authors have not mentioned one of the most famous classic Research & Development (R&D) models used in the creation of disruptive technologies-a unique model of the Defense Advanced Research Projects Agency (DARPA) of the US Department of Defense. The present commentary poses questions about the models currently used in innovative research, known as DARPA-like R&D agencies, and the innovative ecosystems around them.
Related Concept Videos
Plant Breeding and Biotechnology
The Central Dogma
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
Preclinical Development: Overview
Whole Body Regeneration
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Recombinant DNA

